Intercept Pharmaceuticals Inc Shares outstanding
What is the Shares outstanding of Intercept Pharmaceuticals Inc?
The Shares outstanding of Intercept Pharmaceuticals Inc is 41.783M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with shares outstanding similar to Intercept Pharmaceuticals Inc
- Atlantis Japan Growth Fund has Shares outstanding of 41.715M
- Roots has Shares outstanding of 41.717M
- COMPASS Pathways plc has Shares outstanding of 41.731M
- Duxton Broadacre Farms has Shares outstanding of 41.751M
- J. Smart & Co. (Contractors) PLC has Shares outstanding of 41.762M
- Quinto Resources has Shares outstanding of 41.780M
- Intercept Pharmaceuticals Inc has Shares outstanding of 41.783M
- Cequence has Shares outstanding of 41.784M
- Foghorn Therapeutics has Shares outstanding of 41.802M
- Cerence Inc has Shares outstanding of 41.804M
- La-Z-Boy has Shares outstanding of 41.827M
- Otter Tail has Shares outstanding of 41.828M
- Plantronics has Shares outstanding of 41.839M